News

The new dosing strengths, 45mg and 75mg, complement the currently available 30mg, 60mg, 90mg and 120mg dosages. Avinza is a long-acting opioid for patients with moderate to severe

The new offices located in Kiev and Bratislava will support staff in Ukraine and Slovakia, including Covance’s regional network of field-based clinical research associates throughout central and eastern

Lamotrigine chewable tablets, marketed by GlaxoSmithKline as Lamictal chewable dispersible tablets, is a prescription pharmaceutical product used in treating seizures. Taro previously filed a ‘Paragraph IV’ certification challenging

ESBATech, a developer of antibody fragment therapeutics, has initiated a Phase Ib/IIa study in patients undergoing cataract surgery. This study is designed to evaluate the safety, tolerability, and

Approximately 240 of these reductions are corporate positions associated with synergies from the Alpharma acquisition. Approximately 520 of these reductions are associated with the restructuring announced earlier, of

Merck has reported a net income of $1.64 billion, or $0.78 per diluted share, for the fourth quarter of 2008, compared to a net loss of $1.63 billion,

Under the terms of the merger agreement, JLL will commence a tender offer to purchase all of the outstanding shares of PharmaNet at a price of $5 per

PTC Therapeutics, a biopharmaceutical company, has successfully completed patient enrollment in its pivotal clinical trial of PTC124 in patients with nonsense mutation Duchenne and Becker muscular dystrophy. Accrual

The study is an open-label Phase I clinical trial of the safety and tolerability of a single infusion of autologous CD4+ T cells genetically modified at the CCR5